Press Releases

Mithra Announces Injectable Contract with Midas Pharma
16 May 2018
EN FR

Mithra Announces Last Subject Visit in Estelle® Phase III Study in EU/Russia and Completion of Endometrial Substudy
3 May 2018
EN FR

Mithra Announces Positive Donesta® Phase IIb Study Achieving Primary Objective and Confirming Promising Safety Profile
19 April 2018
EN FR

Mithra releases 2017 Annual Report and invitation to its Ordinary General Shareholders’ Meeting
16 April 2018
EN FR

Annual Report 2017
16 April 2018
EN FR

Mithra Signs Principle Agreement for Commercialization of Estelle® in Canada with Women’s Health Specialist Searchlight Pharma
12 April 2018
EN FR

Mithra Applies for Additional Estelle® Patent Based on Positive Hemostasis Data
28 March 2018
EN FR

Mithra Announces Completion of Estelle® Cycles Required in Phase III Contraception Studies
23 March 2018
EN FR

Mithra and Mayne Pharma’s Vaginal Contraceptive Ring Accepted for Filing by FDA
20 March 2018
EN FR

Mithra and Alvogen Sign LSA for Vaginal Contraception Ring in Russia
16 March 2018
EN FR

Mithra Presents Positive Hemostasis Results at ISGE Conference
8 March 2018
EN FR

Mithra Reports 2017 Annual Results
2 March 2018
EN FR